Clinical Trials Browser

OTHER × Glioblastoma × Crizotinib × Clear all

NCT02270034 2022-03-10

Study to Evaluate Safety and Activity of Crizotinib With Temozolomide and Radiotherapy in Newly Diagnosed Glioblastoma

Phase 1 Completed

Glioblastoma